Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-24-024885

CHIEF ACCOUNTING OFFICER gave up 82 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 175 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-10-04 Option exercise +175 26,610 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-10-04 Shares withheld for taxes −82 $24.48 $2,007 26,528 D
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2024-10-04 Option exercise · Restricted Share Unit −175 175 D
Loading xslF345X05/form4-10082024_081027.xml…